×

Lightning Round: Intel, Gilead Sciences, Dolby Labs and More

MannKind : MannKind works as a speculative play only, Cramer said. He prefers Gilead Sciences as the play on pharmaceuticals.

Tortoise Energy : Stay away from TYG. “I don’t want to be levered to the price of oil,” Cramer said, adding that he thinks crude and gas prices are headed lower. “I think that that’s a mistake.”

Dolby Labs : “I think Dolby’s last year’s stock,” Cramer said. Don’t buy DLB.

FPL Group :Con Ed is a better utility play for its dividend yield, Cramer said, while Exelon is the play for growth.

Progress Energy : Progress works for the long term, Cramer said, but again, he prefers Exelon, Con Ed and even Dominion Resources .


Watch the video for Cramer’s latest on Intel and AMD .

Cramer's charitable trust owns Gilead Sciences.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com